Study: HPV Testing for Cervical Cancer Reduces Advanced Cases in Rural India

by: cancercompass

Researchers, say human papillomavirus (HPV) testing for cervical cancer helped reduce the number of advanced cases and deaths from this disease in women living in a high-risk area of rural India.

The New England Journal of Medicine recently published the study, which involved 131,746 healthy women ages 30-59. In 1999 these women were split into four groups; each group was randomly assigned to undergo HPV testing (34,126 women), cytologic testing (32,058 women), VIA (34,074 women) or standard care (31,488 women). Those with positive screenings for precancerous lesions or cancer received appropriate treatment.

After 8 years of research, fewer women in the HPV testing group were diagnosed with advanced cervical cancer compared to the standard care group. More deaths were also reported in the standard care group than in the HPV tested group. There was no significant reduction in the number of advanced cancers or deaths observed in either the cytologic or VIA tested groups, as compared with the standard care group.

Discuss your personal experiences with cervical cancer testing in the Cancer Diagnosis Message Board. Or find other cervical cancer patients, survivors and caregivers at the Cervical Cancer Message Board.